These findings suggest that gain-of-function mutants of SHP2 might promote serine synthesis by activating the expression of PSAT1 and PHGDH, and promote glycine biosynthesis by activating the expression of SHMT2 for leukemia initiation and progression. This evidence concerns the gene PTPN11 and leukemia.